RESMED INC — Director's Dealing 2017

Nov 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-20

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-20	ResMed Common Stock	M	7019	$43.63	Acquired	66409	Direct
2017-11-20	ResMed Common Stock	S	7019	$84.16	Disposed	59390	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-20	ResMed Common Stock Options	$43.63	M	7019	Disposed	2020-03-01	ResMed Commmon Stock (7019)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $83.74 to $84.53. The price reported above reflects the weighted average sale price.

F2: Represents date options first become exercisable. Options vest 1/3 annually each November 11.